Cited by 340Proteoglycans and glycosaminoglycans researchProtease and Inhibitor MechanismsMechanisms of cancer metastasis

The DOI matches its Crossref record; 57 of the 58 references it cites were found in a registry or an index.

Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Open access

Götte, Martin, Yip, George W.·2006·Cancer Research

DOI 10.1158/0008-5472.can-06-1464

Open this paper in CoChat — free account Open PDF

Abstract

Glycosaminoglycans are major constituents of the cancer cell surface and the tumor stroma. The heparan sulfate degrading enzyme heparanase, hyaluronan, and its receptor CD44 are up-regulated in breast cancer, generating a microenvironment that promotes tumor progression and metastasis. Recent experimental and clinical evidence shows that heparanase, hyaluronan, and CD44 regulate cancer cell proliferation, migration, and invasion, as well as tumor-associated angiogenesis and are correlated with patient survival. These findings suggest that they may be used as prognostic factors and targets for breast cancer treatment. (Cancer Res 2006; 66(21): 10233-7)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/0008-5472.can-06-1464

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
High Interstitial Fluid Pressure - an Obstacle in Cancer Therapy
Heldin, C.-H., Rubin, K., Pietras, K., & Östman, A. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1456 · Cited by 2,222
Hyaluronan: from extracellular glue to pericellular cue
Toole, B. P. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1391 · Cited by 2,125
Genomic structure of DNA encoding the lymphocyte homing receptor CD44 reveals at least 12 alternatively spliced exons.
Screaton, G. R., Bell, M. V., Jackson, D. G., Cornélis, F., Gerth, U., & Bell, J. I. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.24.12160 · Cited by 1,016
Mammalian heparanase: Gene cloning, expression and function in tumor progression and metastasis
Vlodavsky, I., Friedmann, Y., Elkin, M., Aingorn, H., Atzmon, R., Ishai-Michaeli, R., Bitan, M., Pappo, O., Peretz, T., Michal, I., et al. (1999) · Nature Medicine · doi:10.1038/10518 · Cited by 803
Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules
Bashkin, P., Doctrow, S. R., Klagsbrun, M., Svahn, C. M., Folkman, J., & Vlodavsky, I. (1989) · Biochemistry · doi:10.1021/bi00430a047 · Cited by 590
The Global Breast Cancer Burden: Variations in Epidemiology and Survival
Hortobágyi, G. N., Salazar, J. D. L. G., Pritchard, K. I., Amadori, D., Haidinger, R., Hudis, C. A., Khaled, H. M., Liu, M.-C., Martín, M., Namer, M., et al. (2005) · Clinical Breast Cancer · doi:10.3816/cbc.2005.n.043 · Cited by 586
Prevalence of CD44+/CD24−/low Cells in Breast Cancer May Not Be Associated with Clinical Outcome but May Favor Distant Metastasis
Abraham, B. K., Fritz, P., McClellan, M., Hauptvogel, P., Athelogou, M., & Brauch, H. B. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1154.11.3 · Cited by 535
Hyaluronan in Peritumoral Stroma and Malignant Cells Associates with Breast Cancer Spreading and Predicts Survival
Auvinen, P., Tammi, R., Parkkinen, J. J., Tammi, M., Ågren, U. M., Johansson, R. T., Hirvikoski, P. P., Eskelinen, M. J., & Kosma, V. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64757-8 · Cited by 494
Recent advances in tumor-targeting anticancer drug conjugates
Jaracz, S., Chen, J., Kuznetsova, L. V., & Ojima, I. (2005) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2005.04.084 · Cited by 491
Identification of sulfated oligosaccharide-based inhibitors of tumor growth and metastasis using novel in vitro assays for angiogenesis and heparanase activity.
Parish, C. R., Freeman, C. G., Brown, K. J., Francis, D. J., & Cowden, W. B. (1999) · PubMed · Cited by 400
Physiological degradation converts the soluble syndecan-1 ectodomain from an inhibitor to a potent activator of FGF-2
Kato, M., Wang, H., Kainulainen, V., Fitzgerald, M. L., Ledbetter, S. R., Ornitz, D. M., & Bernfield, M. R. (1998) · Nature Medicine · doi:10.1038/nm0698-691 · Cited by 337
Heparanases and tumor metastasis
Nakajima, M., Irimura, T., & Nicolson, G. L. (1988) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240360207 · Cited by 307
Regulation of MDR1 Expression and Drug Resistance by a Positive Feedback Loop Involving Hyaluronan, Phosphoinositide 3-Kinase, and ErbB2*♦
Misra, S., Ghatak, S., & Toole, B. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500737200 · Cited by 251
Heparanase Gene Silencing, Tumor Invasiveness, Angiogenesis, and Metastasis
Edovitsky, E., Elkin, M., Zcharia, E., Peretz, T., & Vlodavsky, I. (2004) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djh230 · Cited by 243
Heparanase Induces Vascular Endothelial Growth Factor Expression: Correlation with p38 Phosphorylation Levels and Src Activation
Zetser, A., Bashenko, Y., Edovitsky, E., Levy‐Adam, F., Vlodavsky, I., & Ilan, N. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-1811 · Cited by 239
Hyaluronan-mediated CD44 Interaction with RhoGEF and Rho Kinase Promotes Grb2-associated Binder-1 Phosphorylation and Phosphatidylinositol 3-Kinase Signaling Leading to Cytokine (Macrophage-Colony Stimulating Factor) Production and Breast Tumor Progression
Bourguignon, L., Singleton, P. A., Zhu, H., & Diedrich, F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301885200 · Cited by 237
Regulation of Multidrug Resistance in Cancer Cells by Hyaluronan
Misra, S., Ghatak, S., Zoltan-Jones, A., & Toole, B. P. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c300173200 · Cited by 225
The over-expression of HAS2, Hyal-2 and CD44 is implicated in the invasiveness of breast cancer
Udabage, L., Brownlee, G. R., Nilsson, S. K., & Brown, T. J. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.07.026 · Cited by 223
Processing of the Human Heparanase Precursor and Evidence That the Active Enzyme Is a Heterodimer
Fairbanks, M. B., Mildner, A. M., Leone, J. W., Cavey, G. S., Mathews, W. R., Drong, R. F., Slightom, J. L., Bienkowski, M. J., Smith, C. W., Bannow, C. A., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.42.29587 · Cited by 202
Radiation dose, chemotherapy and risk of osteosarcoma after solid tumours during childhood
Vu, B. L., de Vathaire, F., Shamsaldin, A., Hawkins, M. M., Grimaud, E., Hardiman, C., Diallo, I., Vassal, G., Bessa, E., Campbell, S., et al. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980729)77:3 · Cited by 193
CD44 Attenuates Metastatic Invasion during Breast Cancer Progression
Lopez, J. I., Camenisch, T. D., Stevens, M. V., Sands, B. J., McDonald, J. A., & Schroeder, J. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0863 · Cited by 178
Targeted Delivery of Doxorubicin by HPMA Copolymer-Hyaluronan Bioconjugates
Luo, Y., Bernshaw, N. J., Lu, Z., Kopec̆ek, J., & Prestwich, G. D. (2002) · Pharmaceutical Research · doi:10.1023/a:1015170907274 · Cited by 172
Hyaluronan metabolism: a major paradox in cancer biology
Stern, R. (2005) · Pathologie Biologie · doi:10.1016/j.patbio.2004.12.021 · Cited by 164
Heparanase-1 expression is associated with the metastatic potential of breast cancer
Maxhimer, J. B., Quiros, R. M., Stewart, R., Dowlatshahi, K., Gattuso, P., Fan, M., Prinz, R. A., & Xu, X. (2002) · Surgery · doi:10.1067/msy.2002.125719 · Cited by 153
CD44-Mediated Oncogenic Signaling and Cytoskeleton Activation During Mammary Tumor Progression
Bourguignon, L. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011371523994 · Cited by 152
Heparanase promotes growth, angiogenesis and survival of primary breast tumors
Cohen, I., Pappo, O., Elkin, M., San, T., Bar‐Shavit, R., Hazan, R. B., Peretz, T., Vlodavsky, I., & Abramovitch, R. (2005) · International Journal of Cancer · doi:10.1002/ijc.21552 · Cited by 135
Antisense-Mediated Suppression of Hyaluronan Synthase 2 Inhibits the Tumorigenesis and Progression of Breast Cancer
Udabage, L., Brownlee, G. R., Waltham, M. C., Blick, T., Walker, E. C., Heldin, P., Nilsson, S. K., Thompson, E. W., & Brown, T. J. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-1622 · Cited by 128
A hyaluronan synthase suppressor, 4‐methylumbelliferone, inhibits liver metastasis of melanoma cells
Yoshihara, S., Kon, A., Kudo, D., Nakazawa, H., Kakizaki, I., Sasaki, M., Endo, M., & Takagaki, K. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.03.079 · Cited by 127
Immunohistochemical Detection of c-erbB-2 and p53 in Benign Breast Disease and Breast Cancer Risk
Rohan, T. E., Hartwick, W. J., Miller, A. B., & Kandel, R. A. (1998) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/90.17.1262 · Cited by 106
Role of promoter methylation in regulation of the mammalian heparanase gene
Shteper, P. J., Zcharia, E., Ashhab, Y., Peretz, T., Vlodavsky, I., & Ben‐Yehuda, D. (2003) · Oncogene · doi:10.1038/sj.onc.1207056 · Cited by 105
Expression of Heparanase by Primary Breast Tumors Promotes Bone Resorption in the Absence of Detectable Bone Metastases
Kelly, T. J., Suva, L. J., Huang, Y., MacLeod, V., Miao, H., Walker, R. C., & Sanderson, R. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0749 · Cited by 105
Human heparanase nuclear localization and enzymatic activity
Schubert, S. Y., Ilan, N., Shushy, M., Ben‐Izhak, O., Vlodavsky, I., & Goldshmidt, O. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700084 · Cited by 101
Regulation of heparanase gene expression by estrogen in breast cancer.
Elkin, M., Cohen, I., Zcharia, E., Orgel, A., Guatta-Rangini, Z., Peretz, T., Vlodavsky, I., & Kleinman, H. K. (2003) · PubMed · Cited by 101
Tumor suppressor p53 regulates heparanase gene expression
Baraz, L., Haupt, Y., Elkin, M., Peretz, T., & Vlodavsky, I. (2006) · Oncogene · doi:10.1038/sj.onc.1209425 · Cited by 98
Hyaluronidase reduces human breast cancer xenografts in SCID mice
Shuster, S., Frost, G. I., Csoka, A. B., Formby, B., & Stern, R. (2002) · International Journal of Cancer · doi:10.1002/ijc.10668 · Cited by 95
Early Growth Response Gene 1 (EGR1) Regulates Heparanase Gene Transcription in Tumor Cells
de Mestre, A. M., Rao, S., Hornby, J. R., Soe‐Htwe, T., Khachigian, L. M., & Hulett, M. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m503414200 · Cited by 89
Inhibition of heparanase activity and heparanase‐induced angiogenesis by suramin analogues
Marchetti, D., Reiland, J., Erwin, B., & Roy, M. (2003) · International Journal of Cancer · doi:10.1002/ijc.10930 · Cited by 84
CD44 Expression Is Associated with Increased Survival in Node-Negative Invasive Breast Carcinoma
Diaz, L. K., Zhou, X., Wright, E. T., Cristofanilli, M., Smith, T., Yang, Y., Sneige, N., Şahin, A. A., & Gilcrease, M. Z. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2184 · Cited by 84
Characterization of the Heparan Sulfate and Chondroitin Sulfate Assembly Sites in CD44
Greenfield, B., Wang, W.-C., Marquardt, H., Piepkorn, M. W., Wolff, E. A., Aruffo, A. A., & Bennett, K. L. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.4.2511 · Cited by 81
Serum hyaluronan (hyaluronic acid) in breast cancer patients
Delpech, B., Chevallier, B., Reinhardt, N., Julien, J., Duval, C., Maingonnat, C., Bastit, P., & Asselain, B. J. R. (1990) · International Journal of Cancer · doi:10.1002/ijc.2910460309 · Cited by 79
Proteoglycans: Pericellular and Cell Surface Multireceptors that Integrate External Stimuli in the Mammary Gland
Delehedde, M., Lyon, M., Sergeant, N., Rahmoune, H., & Fernig, D. G. (2001) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1011367423085 · Cited by 74
Breast Cancer Stromal Myxoid Changes Are Associated with Tumor Invasion and Metastasis: A Central Role for Hyaluronan
Wernicke, M., Piñeiro, L. C., Caramutti, D., Dorn, V. G., Raffo, M. M. L., Guixa, H. G., Telenta, M., & Morandi, A. (2003) · Modern Pathology · doi:10.1097/01.mp.0000051582.75890.2d · Cited by 71
Expression of cell adhesion molecules, CD44s and E‐cadherin, and microvessel density in invasive micropapillary carcinoma of the breast
Gong, Y., Sun, X., Huo, L., Wiley, E. L., & Rao, M. S. R. (2005) · Histopathology · doi:10.1111/j.1365-2559.2004.01981.x · Cited by 71
Expression of CD44s, CD44v3 and CD44v6 in benign and malignant breast lesions: correlation and colocalization with hyaluronan
Auvinen, P., Tammi, R., Tammi, M., Johansson, R. T., & Kosma, V. (2005) · Histopathology · doi:10.1111/j.1365-2559.2005.02220.x · Cited by 63
Trans-activation of heparanase promoter by ETS transcription factors
Lu, W., Liu, Y. N., Kang, B.-B., & Chen, J. H. (2003) · Oncogene · doi:10.1038/sj.onc.1206201 · Cited by 63
Hyaluronan-CD44 Promotes Phospholipase C–Mediated Ca2+ Signaling and Cisplatin Resistance in Head and Neck Cancer
Wang, S. J., & Bourguignon, L. (2006) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.132.1.19 · Cited by 54
Enhancement of the anti-tumor immune response using a combination of interferon-γ and B7 expression in an experimental mammary carcinoma
Hurwitz, A. A., Townsend, S. E., Yu, T. F.-Y., Wallin, J. A., & Allison, J. P. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980703)77:1 · Cited by 47
Expression of a CD44 variant and VEGF-C and the implications for lymphatic metastasis and long-term prognosis of human breast cancer.
Watanabe, O., Kinoshita, J., Shimizu, T., Imamura, H., Hirano, A., Okabe, T., Aiba, M., & Ogawa, K. (2005) · PubMed · Cited by 40
Clinicopathological associations of CD44 mRNA and protein expression in primary breast carcinomas
Berner, H. S., Suo, Z., Risberg, B. Å., Villman, K., Karlsson, M. G., & Nesland, J. M. (2003) · Histopathology · doi:10.1046/j.1365-2559.2003.01622.x · Cited by 39
Ductal carcinoma in situ of the breast and heparanase-1 expression: A molecular explanation for more aggressive subtypes
Maxhimer, J. B., Pesce, C. E., Stewart, R., Gattuso, P., Prinz, R. A., & Xu, X. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2004.10.034 · Cited by 31
COX-2 induction by heparanase in the progression of breast cancer
Imada, T., Matsuoka, J., Nobuhisa, T., Okawa, T., Murata, T., Tabuchi, Y., Shirakawa, Y., Ohara, N., Gündüz, M., Nagatsuka, H., et al. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.2.221 · Cited by 31
The role of CD44v3 expression in female breast carcinomas.
Ryś, J., Kruczak, A., Lackowska, B., Jaszcz-Gruchała, A., Brandys, A., Stelmach, A., & Reinfuss, M. (2003) · PubMed · Cited by 25
Phase I and Pharmacokinetic Evaluation of Intravenous Hyaluronic Acid in Combination with Doxorubicin or 5-Fluorouracil
Rosenthal, M. A., Gibbs, P., Brown, T. J., Wong, S., Uren, S. C., Ellis, A. G., Li, L., Heldin, P., & Fox, R. M. (2005) · Chemotherapy · doi:10.1159/000085621 · Cited by 23
An expanding role for antithrombotic therapy in cancer patients
Kakkar, A. K. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)80006-3 · Cited by 23
Sonographic Morphology of Infiltrating Breast Carcinoma
Vignal, P., Meslet, M. R., Roméo, J. M., & Feuilhade, F. (2002) · Journal of Ultrasound in Medicine · doi:10.7863/jum.2002.21.5.531 · Cited by 12
Untitled work
Miao (1999) · doi:10.1002/(sici)1097-0215(19991029)83:3

Sorted by citations

Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features
Creighton, C. J., Li, X., Landis, M. D., Dixon, J. M., Neumeister, V. M., Sjolund, A. B., Rimm, D. L., Wong, H. H., Rodriguez, A. A., Herschkowitz, J. I., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0905718106 · Cited by 1,414
Significance of CD90+ Cancer Stem Cells in Human Liver Cancer
Yang, Z. F., Ho, D. W., Ng, M. N., Lau, C. K., Yu, W. C., Ngai, P., Chu, P., Lam, C. T., Poon, R. T. P., & Fan, S. T. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.013 · Cited by 1,188
Fibroblast heterogeneity in the cancer wound
Öhlund, D., Elyada, E., & Tuveson, D. A. (2014) · The Journal of Experimental Medicine · doi:10.1084/jem.20140692 · Cited by 982
The JAK2/STAT3 signaling pathway is required for growth of CD44+CD24– stem cell–like breast cancer cells in human tumors
Marotta, L. L. C., Almendro, V., Marusyk, A., Shipitsin, M. V., Schemme, J., Walker, S. R., Bloushtain-Qimron, N., Kim, J. J., Choudhury, S. A., Maruyama, R., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44745 · Cited by 922
Interstitial Fluid and Lymph Formation and Transport: Physiological Regulation and Roles in Inflammation and Cancer
Wiig, H., & Swartz, M. A. (2012) · Physiological Reviews · doi:10.1152/physrev.00037.2011 · Cited by 739

See all 340

Authors: Götte, M., & Yip, G. W.
Affiliations: 1Department of Obstetrics and Gynecology, Münster University Hospital, Münster, Germany and
National University of Singapore (SG)
ORCID: Yip, George W.
Venue: Cancer Research
Publisher: American Association for Cancer Research (AACR)
Published: 2006-11-01
Volume: 66
Issue: 21
Pages: 10233-10237
ISSN: 0008-5472 (ISSN-L)
1538-7445
DOI: 10.1158/0008-5472.can-06-1464
OpenAlex: W2134709252
Cited by: 340
References: 58
Citations by year: 2026: 3 · 2025: 7 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 14 · 2019: 9 · 2018: 16 · 2017: 22 · 2016: 22 · 2015: 19 · 2014: 25 · 2013: 28 · 2012: 24
FWCI: 1.57
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Cancer Research (publishedVersion)
PubMed (publishedVersion)
National University of Singapore (submittedVersion)
Funders: Deutsche Forschungsgemeinschaft
Medical Research Council
National Medical Research Council
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Protease and Inhibitor Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Mechanisms of cancer metastasis
Keywords: heparanase, hyaluronic acid, CD44, breast cancer, glycosaminoglycans, tumor microenvironment, tumor stroma, metastasis, tumor progression, angiogenesis, tumor cell proliferation, cell migration and invasion, prognostic factors, therapeutic target
MeSH terms: Heparanase, Breast Neoplasms, Female, Glucuronidase, Humans, Hyaluronic Acid, Neoplasm Invasiveness, Hyaluronan Receptors, Cell Proliferation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Heparanase, Hyaluronan, and CD44 in Cancers: A Breast Carcinoma Perspective

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks